Skip to main content

Advertisement

SpringerLink
Log in

Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. La Vecchia C, Tavani A. Female hormones and benign liver tumours. Dig Liver Dis. 2006;38(8):535–6.

    Article  PubMed  Google Scholar 

  2. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27(1):39–45. doi:10.1159/000268406.

    Article  CAS  PubMed  Google Scholar 

  3. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481–9. doi:10.1002/hep.22995.

    Article  PubMed  Google Scholar 

  4. Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology. 2007;46(1):140–6.

    Article  PubMed  Google Scholar 

  5. Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology. 2003;228:465–72.

    Article  PubMed  Google Scholar 

  6. Bioulac-Sage P, Laumonier H, Laurent C, et al. Hepatocellular adenoma: what is new in 2008. Hepatol Int. 2008;2(3):316–21.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Albiin N. MRI of focal liver lesions. Curr Med Imaging Rev. 2012;8(2):107–16. doi:10.2174/157340512800672216.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology. 2011;54(6):2227–37. doi:10.1002/hep.24679.

    Article  PubMed  Google Scholar 

  9. Purysko AS, Remer EM, Veniero JC. Focal liver lesion detection and characterization with GD-EOB-DTPA. Clin Radiol. 2011;66(7):673–84. doi:10.1016/j.crad.2011.01.014.

    Article  CAS  PubMed  Google Scholar 

  10. Palmucci S. Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol. 2014;27(6(7)):477–85. doi:10.4254/wjh.v6.i7.477.

    Article  Google Scholar 

  11. Filippone A, Blakeborough A, Breuer J, et al. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging. 2010;31(2):356–64. doi:10.1002/jmri.22054.

    Article  PubMed  Google Scholar 

  12. Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect. J Hepatol. 2012;57:421–9. doi:10.1016/j.jhep.2012.01.031.

    Article  PubMed  Google Scholar 

  13. Iannicelli E, Di Pietropaolo M, Marignani M, et al. Gadoxetic acid-enhanced MRI for hepatocellular carcinoma and hypointense nodule observed in the hepatobiliary phase. Radiol Med. 2014;119:367–76. doi:10.1007/s11547-013-0364-x.

    PubMed  Google Scholar 

  14. Di Pietropaolo M, Briani C, Federici GF et al. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Clin Imaging 2015;7. doi:10.1016/j.clinimag.2014.12.020.

  15. Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520–9. doi:10.1148/radiol.11101742.

    Article  PubMed  Google Scholar 

  16. Bieze M, van den Esschert JW, Nio CY, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199(1):26–34. doi:10.2214/AJR.11.7750.

    Article  PubMed  Google Scholar 

  17. Agarwal S, Fuentes-Orrego JM, Arnason T, et al. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2014;203(4):W408–14. doi:10.2214/AJR.13.12251.

  18. Sempoux C, Balabaud C, Bioulac-Sage P. Pictures of focal nodular hyperplasia and hepatocellular adenomas. World J Hepatol. 2014;27(6(8)):580–95. doi:10.4254/wjh.v6.i8.580.

    Google Scholar 

  19. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43(3):515–24.

    Article  CAS  PubMed  Google Scholar 

  20. Katabathina VS, Menias CO, Shanbhogue AK, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31(6):1529–43. doi:10.1148/rg.316115527.

    Article  PubMed  Google Scholar 

  21. Ronot M, Bahrami S, Calderaro J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53(4):1182–91. doi:10.1002/hep.24147.

    Article  PubMed  Google Scholar 

  22. Rebouissou S, Amessou M, Couchy G, et al. Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;8(457(7226):200–4. doi:10.1038/nature07475.

    Article  Google Scholar 

  23. Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med. 2014;138(8):1090–7. doi:10.5858/arpa.2013-0183-RA.

    Article  PubMed  Google Scholar 

  24. Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808–18. doi:10.1002/hep.22417.

    Article  PubMed  Google Scholar 

  25. Thomeer MG, ME Bröker E, de Lussanet Q, et al. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings. Diagn Interv Radiol. 2014;20(3):193–9. doi:10.5152/dir.2013.13315.

    Article  PubMed Central  PubMed  Google Scholar 

  26. van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261(1):172–81. doi:10.1148/radiol.11110023.

    Article  PubMed  Google Scholar 

  27. Grazioli L, Olivetti L, Mazza G et al. MR imaging of hepatocellular adenomas and differential diagnosis dilemma. Int J Hepatol 2013;374170. doi:10.1155/2013/374170

  28. Kim MJ, Rhee HJ, Jeong HT. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol. 2012;199(5):W575–86. doi:10.2214/AJR.11.8205.

    Article  PubMed  Google Scholar 

  29. Thomeer MG, Willemssen FE, Biermann KK, et al. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging. 2014;39(5):1259–64. doi:10.1002/jmri.24281.

    Article  PubMed  Google Scholar 

  30. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48(1):163–70.

    Article  CAS  PubMed  Google Scholar 

  31. Strazzabosco M, Fabris L. Development of the bile ducts: essentials for the clinical hepatologist. J Hepatol. 2012;56(5):1159–70. doi:10.1016/j.jhep.2011.09.022.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Bioulac-Sage P, Taouji S, Possenti L, et al. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32:1217–21.

    Article  PubMed  Google Scholar 

  33. Bioulac-Sage P, Sempoux C, Possenti L, et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol. 2013;2013:253261.

    PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethical Standards

The authors declare no conflict of interest in this case report. Informed consent was obtained from the patient.

Author information

Authors and Affiliations

  1. Department of Radiology, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant’Andrea Hospital, Via di Grottarossa 1035, 00189, Rome, Italy

    Marco Di Pietropaolo, Chiara Briani, Francesco Carbonetti, Vincenzo David & Elsa Iannicelli

  2. Department of Clinical and Molecular Sciences, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant’Andrea Hospital, Via di Grottarossa 1035, 00189, Rome, Italy

    Emanuela Pilozzi

Authors
  1. Marco Di Pietropaolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Briani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emanuela Pilozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Carbonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo David
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elsa Iannicelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Di Pietropaolo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Pietropaolo, M., Briani, C., Pilozzi, E. et al. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature. J Gastrointest Canc 46, 421–425 (2015). https://doi.org/10.1007/s12029-015-9715-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-015-9715-2

Keywords

Search

Navigation